Company news
Clover Biopharmaceuticals Ltd. news in 2023
Clover Biopharmaceuticals Ltd.'s news releases, calls and decks from 2023, newest first.
Clover Initiates Phase Ⅰ Clinical Trial for RSV Vaccine Candidate
December 12, 2023
Clover Launches Quadrivalent Seasonal Influenza Vaccine in Mainland China
September 11, 2023
Clover Provides Updates on Business and R&D Pipeline Development
July 10, 2023
Clover Expands Sales and Distribution Network for Upcoming Quadrivalent Seasonal Influenza Vaccine Launch in China
May 23, 2023
Clover Announces Corporate Updates and Full Year 2022 Financial Results
March 28, 2023
Clover Biopharmaceuticals Announces Corporate Updates and Full Year 2022 Financial Results
March 29, 2023
Clover Enters into Exclusive Agreement to Commercialize Quadrivalent Seasonal Influenza Vaccine in Mainland China
February 19, 2023
Clover Biopharmaceuticals Launches COVID-19 Booster Vaccine in the People's Republic of China
February 15, 2023
UPDATE -- Clover Launches COVID-19 Booster Vaccine in the People’s Republic of China
February 14, 2023
Decks in 2023
- Investor Presentation (August 2023)
Investor deck · 31 slides · August 2023